GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00064029 | Cervix | CC | mRNA catabolic process | 56/2311 | 232/18723 | 4.81e-07 | 1.83e-05 | 56 |
GO:00064019 | Cervix | CC | RNA catabolic process | 62/2311 | 278/18723 | 2.18e-06 | 6.56e-05 | 62 |
GO:003425010 | Cervix | CC | positive regulation of cellular amide metabolic process | 40/2311 | 162/18723 | 1.11e-05 | 2.41e-04 | 40 |
GO:000641710 | Cervix | CC | regulation of translation | 89/2311 | 468/18723 | 1.86e-05 | 3.46e-04 | 89 |
GO:00009567 | Cervix | CC | nuclear-transcribed mRNA catabolic process | 30/2311 | 112/18723 | 2.60e-05 | 4.37e-04 | 30 |
GO:004572710 | Cervix | CC | positive regulation of translation | 33/2311 | 136/18723 | 9.09e-05 | 1.20e-03 | 33 |
GO:00467008 | Cervix | CC | heterocycle catabolic process | 80/2311 | 445/18723 | 3.23e-04 | 3.42e-03 | 80 |
GO:00346559 | Cervix | CC | nucleobase-containing compound catabolic process | 74/2311 | 407/18723 | 3.77e-04 | 3.88e-03 | 74 |
GO:00442709 | Cervix | CC | cellular nitrogen compound catabolic process | 79/2311 | 451/18723 | 7.80e-04 | 6.91e-03 | 79 |
GO:00194398 | Cervix | CC | aromatic compound catabolic process | 79/2311 | 467/18723 | 2.14e-03 | 1.54e-02 | 79 |
GO:00064139 | Cervix | CC | translational initiation | 25/2311 | 118/18723 | 4.54e-03 | 2.75e-02 | 25 |
GO:19013618 | Cervix | CC | organic cyclic compound catabolic process | 80/2311 | 495/18723 | 6.77e-03 | 3.72e-02 | 80 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CTIF | SNV | Missense_Mutation | | c.1124A>G | p.Asp375Gly | p.D375G | O43310 | protein_coding | deleterious(0.01) | possibly_damaging(0.904) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
CTIF | SNV | Missense_Mutation | novel | c.697N>T | p.Pro233Ser | p.P233S | O43310 | protein_coding | tolerated_low_confidence(0.17) | possibly_damaging(0.67) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
CTIF | SNV | Missense_Mutation | novel | c.1394N>A | p.Arg465His | p.R465H | O43310 | protein_coding | deleterious(0.01) | possibly_damaging(0.731) | TCGA-EC-A24G-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
CTIF | SNV | Missense_Mutation | novel | c.518N>T | p.Pro173Leu | p.P173L | O43310 | protein_coding | deleterious_low_confidence(0) | probably_damaging(1) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CTIF | SNV | Missense_Mutation | rs370208252 | c.994N>A | p.Glu332Lys | p.E332K | O43310 | protein_coding | deleterious_low_confidence(0.01) | possibly_damaging(0.455) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CTIF | SNV | Missense_Mutation | novel | c.264A>C | p.Lys88Asn | p.K88N | O43310 | protein_coding | deleterious_low_confidence(0.01) | benign(0.372) | TCGA-EY-A1GQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | taxol | SD |
CTIF | SNV | Missense_Mutation | novel | c.290N>T | p.Thr97Met | p.T97M | O43310 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.707) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CTIF | SNV | Missense_Mutation | rs369443953 | c.805N>T | p.Arg269Cys | p.R269C | O43310 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.736) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CTIF | deletion | Frame_Shift_Del | | c.239delN | p.Pro82HisfsTer77 | p.P82Hfs*77 | O43310 | protein_coding | | | TCGA-D1-A0ZO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CTIF | SNV | Missense_Mutation | | c.1282N>G | p.Ser428Gly | p.S428G | O43310 | protein_coding | deleterious(0.01) | possibly_damaging(0.888) | TCGA-CC-A7IJ-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |